Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared

Area of Science:

• Biochemistry
• Clinical Chemistry
• Orthopedics

Background:

• Bone resorption (BR) is a critical process in bone remodeling.
• Accurate measurement of BR is essential for diagnosing and monitoring bone diseases.
• Existing assays for BR have varying clinical performance.

Purpose of the Study:

• To compare the clinical performance of four bone resorption assays: hydroxyproline (HYP), galactosyl hydroxylysine (GHYL), deoxypyridinoline (DPD), and pyridinoline (PYD).
• To evaluate their discrimination power and accuracy across different rates of bone resorption.

Main Methods:

• Assays compared: HYP, GHYL, DPD, and PYD.
• Subjects grouped by bone resorption rates: normal, mildly increased, high, and very high.
• Clinical performance assessed using Z score for discrimination power and ROC analysis for accuracy.

Main Results:

• All four assays demonstrated similar discrimination power and accuracy in high and very-high bone resorption groups.
• In the mildly increased bone resorption group, DPD, GHYL, and PYD exhibited superior discrimination power and accuracy compared to HYP.
• Assay performance was comparable for large changes in bone resorption but differed for modest changes.

Conclusions:

• Hydroxyproline (HYP) assay is less accurate for detecting modest changes in bone resorption compared to DPD, GHYL, and PYD.
• DPD, GHYL, and PYD are more suitable for assessing subtle alterations in bone resorption rates.
• These findings aid in selecting the most appropriate bone resorption assay for clinical applications.